Ocular Surface Health Examination.
An examination of the ocular surface with attention to the function of the eyelids, meibomian glands, cornea, and root causes of Dry Eye Syndrome.
Information for the Ocular Surface Work-Up
The ocular surface work-up includes a variety of both subjective and objective tests (Lipiscan, Tear Osmolarity, and InflammaDry) to assess the root cause of ocular surface disease and dry eyes.
Please allow ample time for your visit, since the entire evaluation, discussion, and treatment proposal is around 85 minutes. The Ocular Surface Work-Up can be scheduled on any day of the week, however, to enable the most accurate and precise data collection, ocular drops should NOT be utilized two (2) hours prior to appointment.
The total cost of the Ocular Surface Work-Up is $175. At this time, medical nor vision insurances do not cover this type of examination. Nonetheless, we can bill the Tear Osmolarity and InflammaDry tests to your medical insurance for payment consideration on your behalf.
LipiScan Dynamic Meibomian Imager (DMI) is an ophthalmic imaging device intended for use by a physician or trained optometric technician in adult patients to capture, archive, manipulate, and store digital images of the Meibomian glands. The Meibomian glands are located along the rims of the eyelid and they produce meibum, an oily substance that prevents evaporation of the eye’s tear film. These images allow the physician to identify any truncation, elimination, and/or blockage of these glands, which may be the cause of dry eyes.
The TearLab Osmolarity test is used to test the homeostatic osmo-regulation of the tears, and is a key biomarker to identify both aqueous deficiency and its relation to Dry Eye Disease by collecting a small sample of tears and analyzing the tear osmolarity.
InflammaDry is a rapid, immunoassay test for the visual, qualitative, in vitro detection of elevated levels of the MMP-9 protein in human tears, from patients suspected of having dry eye. MMP-9 is a nonspecific inflammatory marker that has consistently been shown to be elevated in the tears of patients with dry eyes. InflammaDry is to be used to aid in the diagnosis of dry eye, in conjunction with other methods of clinical evaluation.